$30.15
0.742.52%
Last update: Nov 9, 10:50 AM
Agios Pharmaceuticals Inc
AGIONASDAQ
The average analyst price target for Agios Pharmaceuticals is $46.54, 54.4% above the current price. Of 10 analysts, 7 rate it Buy and 3 Hold. Targets range from $32 to $65. The latest change came on Nov 6, 2026, when Truist Securities lowered its price target on Agios Pharmaceuticals from $37 to $35 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
